Induction of cyclin-dependent kinase inhibitors and G1 prolongation by the chemopreventive agent N-acetylcysteine

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1869-1872

  Liu, Ming ^a   Wikonkal, Norbert M ^a   Brash, Douglas E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CYCLIN DEPENDENT KINASE INHIBITOR; GLUTATHIONE; PROTEIN P16; PROTEIN P21; PROTEIN P53; TROLOX C;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; GENE INDUCTION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCYSTEINE; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CELL CYCLE; CELL LINE; CHROMANS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FIBROBLASTS; FREE RADICAL SCAVENGERS; G1 PHASE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; GLUTATHIONE; HUMANS; KERATINOCYTES; MICE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PAPILLOMA; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032823875     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1869     Document Type: Article

References (28)

1. Flora, S.D., Astengo, M., Serra, D. and Bennicelli, C. (1986) Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett., 32, 235-241.
2. Rostein, J.B. and Slaga, T.J. (1988) Anticarcinogenesis mechanism, as evaluated in the multistage mouse skin model. Mutat. Res., 202, 421-427.
3. Steele, V.E., Kelloff, G.J., Wilkinson, B.P. and Arnold, J.T. (1990) Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res., 50, 2068-2074.
4. Pereira, M.A. and Khoury, M.D. (1991) Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett., 61, 27-33.
5. Flora, S.D., Izzotti, A., D'Agostino, F., Balansky, R. and Cesarone, C.F. (1992) Chemopreventive properties of N-acetylcysteine and other thiols. In Wattenberg, L., Lipkin, M., Boone, C.W. and Kelloff, G.J. (eds) Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 183-194.
6. Izzotti, A., D'Agostini, F., Bagnasco, M., Scatolini, L., Rovida, A., Balansky, R.M., Cesarone, C.F. and De Flora, S. (1994) Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res., 54, 1994s-1998s.
7. Aruoma, O.I., Halliwell, B., Hoey, B.M. and Butler, J. (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Rad. Biol. Med., 6, 593-597.
8. Burgunder, J.M., Varriale, A. and Lauterburg, B.H. (1989) Effect of N-acetylcysteine on plasma cysleine and glutathione following paracetamol administration. Eur. J. Clin. Pharmacol., 36, 127-131.
9. Smilkstein, M.J., Knapp, G.L., Kulig, K.W. and Rumack, B.J. (1988) Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N. Engl. J. Med., 319, 1557-1562.
10. Solen, G. (1993) Radioprotective effect of N-acetylcysteine in vitro using the induction of DNA breaks as end-point. Int. J. Radiat. Biol, 64, 359-366.
11. Yunis, A.A., Lim, L.O. and Arimura, G.K. (1986) DNA damage induced by chloramphenicol and nitroso-chloramphenicol: protection by N-acetylcysteine. Respiration, 50 (suppl.), 50-55.
12. Chan, J.Y.H., Stout, D.L. and Becker, F.F. (1986) Protective role of thiols in carcinogen-induced DNA damage in rat liver. Carcinogenesis, 7, 1621-1624.
13. Holdiness, M.R. (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin. Pharmacokinet., 20, 123-134.
14. Liu, M., Pelling, J.C., Ju, J., Chu, E. and Brash, D.E. (1998) Antioxidant action via p53-mediated apoptosis. Cancer Res., 58, 1723-1729.
15. Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res., 48, 165-169.
16. Azzoli, C.G., Sagar, M., Wu, A., Lowry, D., Hennings, H., Morgan, D.L. and Weinberg, W.C. (1998) Cooperation of p53 loss of function and v-Ha-ras in transformation of mouse keratinocyte cell lines. Mol. Carcinog., 21, 50-61.
17. Harney, D.M and Levine, A.J. (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5, 2375-2385.
18. Dlugosz, A.A., Glick, A.B., Tennenbaum, J., Weinberg, W.C. and Yuspa, S.H. (1995) Isolation and utilization of epidermal keratinocytes for oncogene research. Methods Enzymol., 254, 3-21.
19. 1 checkpoint control. Cell, 82, 675-684.
20. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D. and DePinho, R.A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85, 27-37.
21. Liu, M. and Pelling, J.C. (1995) UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene, 10, 1955-1960.
22. INK4a. Exp. Cell Res., 237, 7-13.
23. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont, P.J. (1997) Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science, 275, 1649-1652.
24. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev., 10, 1054-1072.
25. Shiohara, M., El-Deiry, W.S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D.L., Vogelstein, B. and Koeffler, H.P. (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood, 84, 3781-3784.
26. Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene, 14, 1875-1882.
27. -/- human cancer cells. Cancer Res., 56, 2250-2255.
28. Waga, S., Hannon, G.J., Beach, D. and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 369, 574-578.